Levels of the Rab GDP dissociation inhibitor (GDI) are altered in the prenatal restrain stress mouse model of schizophrenia and are differentially regulated by the mGlu2/3 receptor agonists, LY379268 and LY354740

Rosamaria Orlando, Marina Borro, Marta Motolese, Gemma Molinaro, Sergio Scaccianoce, Alessandra Caruso, Luigi Di Nuzzo, Filippo Caraci, Francesco Matrisciano, Anna Pittaluga, Jerome Mairesse, Maurizio Simmaco, Robert Nisticò, James A. Monn, Ferdinando Nicoletti

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

LY379268 and LY354740, two agonists of mGlu2/3 metabotropic glutamate receptors, display different potencies in mouse models of schizophrenia. This differential effect of the two drugs remains unexplained. We performed a proteomic analysis in cultured cortical neurons challenged with either LY379268 or LY354740. Among the few proteins that were differentially influenced by the two drugs, Rab GDP dissociation inhibitor-β (Rab GDIβ) was down-regulated by LY379268 and showed a trend to an up-regulation in response to LY354740. In cultured hippocampal neurons, LY379268 selectively down-regulated the α isoform of Rab GDI. Rab GDI inhibits the activity of the synaptic vesicle-associated protein, Rab3A, and is reduced in the brain of schizophrenic patients. We examined the expression of Rab GDI in mice exposed to prenatal stress ("PRS mice"), which have been described as a putative model of schizophrenia. Rab GDIα protein levels were increased in the hippocampus of PRS mice at postnatal days (PND)1 and 21, but not at PND60. At PND21, PRS mice also showed a reduced depolarization-evoked [3H]d-aspartate release in hippocampal synaptosomes. The increase in Rab GDIα levels in the hippocampus of PRS mice was reversed by a 7-days treatment with LY379268 (1 or 10 mg/kg, i.p.), but not by treatment with equal doses of LY354740. These data strengthen the validity of PRS mice as a model of schizophrenia, and show for the first time a pharmacodynamic difference between LY379268 and LY354740 which might be taken into account in an attempt to explain the differential effect of the two drugs across mouse models.

Original languageEnglish (US)
Pages (from-to)133-144
Number of pages12
JournalNeuropharmacology
Volume86
DOIs
StatePublished - Jan 1 2014

Fingerprint

eglumetad
LY 379268
Guanine Nucleotide Dissociation Inhibitors
Schizophrenia
rab3A GTP-Binding Protein
Hippocampus
Pharmaceutical Preparations
Neurons
Synaptosomes
Synaptic Vesicles
Aspartic Acid
Proteomics
Protein Isoforms
Proteins
Up-Regulation

Keywords

  • LY354740
  • LY379268
  • Prenatal stress
  • Rab GDI
  • Schizophrenia

ASJC Scopus subject areas

  • Pharmacology
  • Cellular and Molecular Neuroscience

Cite this

Levels of the Rab GDP dissociation inhibitor (GDI) are altered in the prenatal restrain stress mouse model of schizophrenia and are differentially regulated by the mGlu2/3 receptor agonists, LY379268 and LY354740. / Orlando, Rosamaria; Borro, Marina; Motolese, Marta; Molinaro, Gemma; Scaccianoce, Sergio; Caruso, Alessandra; Di Nuzzo, Luigi; Caraci, Filippo; Matrisciano, Francesco; Pittaluga, Anna; Mairesse, Jerome; Simmaco, Maurizio; Nisticò, Robert; Monn, James A.; Nicoletti, Ferdinando.

In: Neuropharmacology, Vol. 86, 01.01.2014, p. 133-144.

Research output: Contribution to journalArticle

Orlando, R, Borro, M, Motolese, M, Molinaro, G, Scaccianoce, S, Caruso, A, Di Nuzzo, L, Caraci, F, Matrisciano, F, Pittaluga, A, Mairesse, J, Simmaco, M, Nisticò, R, Monn, JA & Nicoletti, F 2014, 'Levels of the Rab GDP dissociation inhibitor (GDI) are altered in the prenatal restrain stress mouse model of schizophrenia and are differentially regulated by the mGlu2/3 receptor agonists, LY379268 and LY354740', Neuropharmacology, vol. 86, pp. 133-144. https://doi.org/10.1016/j.neuropharm.2014.07.009
Orlando, Rosamaria ; Borro, Marina ; Motolese, Marta ; Molinaro, Gemma ; Scaccianoce, Sergio ; Caruso, Alessandra ; Di Nuzzo, Luigi ; Caraci, Filippo ; Matrisciano, Francesco ; Pittaluga, Anna ; Mairesse, Jerome ; Simmaco, Maurizio ; Nisticò, Robert ; Monn, James A. ; Nicoletti, Ferdinando. / Levels of the Rab GDP dissociation inhibitor (GDI) are altered in the prenatal restrain stress mouse model of schizophrenia and are differentially regulated by the mGlu2/3 receptor agonists, LY379268 and LY354740. In: Neuropharmacology. 2014 ; Vol. 86. pp. 133-144.
@article{c5761005740f486b934bedbcebf754f6,
title = "Levels of the Rab GDP dissociation inhibitor (GDI) are altered in the prenatal restrain stress mouse model of schizophrenia and are differentially regulated by the mGlu2/3 receptor agonists, LY379268 and LY354740",
abstract = "LY379268 and LY354740, two agonists of mGlu2/3 metabotropic glutamate receptors, display different potencies in mouse models of schizophrenia. This differential effect of the two drugs remains unexplained. We performed a proteomic analysis in cultured cortical neurons challenged with either LY379268 or LY354740. Among the few proteins that were differentially influenced by the two drugs, Rab GDP dissociation inhibitor-β (Rab GDIβ) was down-regulated by LY379268 and showed a trend to an up-regulation in response to LY354740. In cultured hippocampal neurons, LY379268 selectively down-regulated the α isoform of Rab GDI. Rab GDI inhibits the activity of the synaptic vesicle-associated protein, Rab3A, and is reduced in the brain of schizophrenic patients. We examined the expression of Rab GDI in mice exposed to prenatal stress ({"}PRS mice{"}), which have been described as a putative model of schizophrenia. Rab GDIα protein levels were increased in the hippocampus of PRS mice at postnatal days (PND)1 and 21, but not at PND60. At PND21, PRS mice also showed a reduced depolarization-evoked [3H]d-aspartate release in hippocampal synaptosomes. The increase in Rab GDIα levels in the hippocampus of PRS mice was reversed by a 7-days treatment with LY379268 (1 or 10 mg/kg, i.p.), but not by treatment with equal doses of LY354740. These data strengthen the validity of PRS mice as a model of schizophrenia, and show for the first time a pharmacodynamic difference between LY379268 and LY354740 which might be taken into account in an attempt to explain the differential effect of the two drugs across mouse models.",
keywords = "LY354740, LY379268, Prenatal stress, Rab GDI, Schizophrenia",
author = "Rosamaria Orlando and Marina Borro and Marta Motolese and Gemma Molinaro and Sergio Scaccianoce and Alessandra Caruso and {Di Nuzzo}, Luigi and Filippo Caraci and Francesco Matrisciano and Anna Pittaluga and Jerome Mairesse and Maurizio Simmaco and Robert Nistic{\`o} and Monn, {James A.} and Ferdinando Nicoletti",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.neuropharm.2014.07.009",
language = "English (US)",
volume = "86",
pages = "133--144",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Levels of the Rab GDP dissociation inhibitor (GDI) are altered in the prenatal restrain stress mouse model of schizophrenia and are differentially regulated by the mGlu2/3 receptor agonists, LY379268 and LY354740

AU - Orlando, Rosamaria

AU - Borro, Marina

AU - Motolese, Marta

AU - Molinaro, Gemma

AU - Scaccianoce, Sergio

AU - Caruso, Alessandra

AU - Di Nuzzo, Luigi

AU - Caraci, Filippo

AU - Matrisciano, Francesco

AU - Pittaluga, Anna

AU - Mairesse, Jerome

AU - Simmaco, Maurizio

AU - Nisticò, Robert

AU - Monn, James A.

AU - Nicoletti, Ferdinando

PY - 2014/1/1

Y1 - 2014/1/1

N2 - LY379268 and LY354740, two agonists of mGlu2/3 metabotropic glutamate receptors, display different potencies in mouse models of schizophrenia. This differential effect of the two drugs remains unexplained. We performed a proteomic analysis in cultured cortical neurons challenged with either LY379268 or LY354740. Among the few proteins that were differentially influenced by the two drugs, Rab GDP dissociation inhibitor-β (Rab GDIβ) was down-regulated by LY379268 and showed a trend to an up-regulation in response to LY354740. In cultured hippocampal neurons, LY379268 selectively down-regulated the α isoform of Rab GDI. Rab GDI inhibits the activity of the synaptic vesicle-associated protein, Rab3A, and is reduced in the brain of schizophrenic patients. We examined the expression of Rab GDI in mice exposed to prenatal stress ("PRS mice"), which have been described as a putative model of schizophrenia. Rab GDIα protein levels were increased in the hippocampus of PRS mice at postnatal days (PND)1 and 21, but not at PND60. At PND21, PRS mice also showed a reduced depolarization-evoked [3H]d-aspartate release in hippocampal synaptosomes. The increase in Rab GDIα levels in the hippocampus of PRS mice was reversed by a 7-days treatment with LY379268 (1 or 10 mg/kg, i.p.), but not by treatment with equal doses of LY354740. These data strengthen the validity of PRS mice as a model of schizophrenia, and show for the first time a pharmacodynamic difference between LY379268 and LY354740 which might be taken into account in an attempt to explain the differential effect of the two drugs across mouse models.

AB - LY379268 and LY354740, two agonists of mGlu2/3 metabotropic glutamate receptors, display different potencies in mouse models of schizophrenia. This differential effect of the two drugs remains unexplained. We performed a proteomic analysis in cultured cortical neurons challenged with either LY379268 or LY354740. Among the few proteins that were differentially influenced by the two drugs, Rab GDP dissociation inhibitor-β (Rab GDIβ) was down-regulated by LY379268 and showed a trend to an up-regulation in response to LY354740. In cultured hippocampal neurons, LY379268 selectively down-regulated the α isoform of Rab GDI. Rab GDI inhibits the activity of the synaptic vesicle-associated protein, Rab3A, and is reduced in the brain of schizophrenic patients. We examined the expression of Rab GDI in mice exposed to prenatal stress ("PRS mice"), which have been described as a putative model of schizophrenia. Rab GDIα protein levels were increased in the hippocampus of PRS mice at postnatal days (PND)1 and 21, but not at PND60. At PND21, PRS mice also showed a reduced depolarization-evoked [3H]d-aspartate release in hippocampal synaptosomes. The increase in Rab GDIα levels in the hippocampus of PRS mice was reversed by a 7-days treatment with LY379268 (1 or 10 mg/kg, i.p.), but not by treatment with equal doses of LY354740. These data strengthen the validity of PRS mice as a model of schizophrenia, and show for the first time a pharmacodynamic difference between LY379268 and LY354740 which might be taken into account in an attempt to explain the differential effect of the two drugs across mouse models.

KW - LY354740

KW - LY379268

KW - Prenatal stress

KW - Rab GDI

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=84905384447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905384447&partnerID=8YFLogxK

U2 - 10.1016/j.neuropharm.2014.07.009

DO - 10.1016/j.neuropharm.2014.07.009

M3 - Article

C2 - 25063582

AN - SCOPUS:84905384447

VL - 86

SP - 133

EP - 144

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

ER -